Adaptimmune Therapeutics shares owned by Baker Bros. Advisors
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Baker Bros. Advisors
from 13F filings
Historical chart of Baker Bros. Advisors investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Baker Bros. Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $2.3M | 2.3M | 0.97 |
| 2024-03-31 | $17M | 11M | 1.58 |
| 2023-12-31 | $8.7M | 11M | 0.79 |
| 2023-09-30 | $8.6M | 11M | 0.78 |
| 2023-06-30 | $10M | 11M | 0.93 |
| 2023-03-31 | $11M | 9.8M | 1.09 |
| 2022-12-31 | $14M | 9.8M | 1.46 |
| 2022-09-30 | $11M | 9.8M | 1.08 |
| 2022-06-30 | $17M | 9.8M | 1.70 |
| 2022-03-31 | $20M | 9.8M | 2.06 |
| 2021-12-31 | $37M | 9.8M | 3.75 |
| 2021-09-30 | $51M | 9.8M | 5.17 |
| 2021-06-30 | $42M | 9.8M | 4.26 |
| 2021-03-31 | $52M | 9.8M | 5.31 |
| 2020-12-31 | $53M | 9.8M | 5.39 |
| 2020-09-30 | $51M | 6.3M | 7.98 |
| 2020-06-30 | $67M | 6.7M | 10.01 |
| 2020-03-31 | $10M | 3.7M | 2.72 |
| 2018-06-30 | $1.2M | 100k | 11.87 |
| 2018-03-31 | $1.1M | 100k | 11.23 |
| 2017-12-31 | $668k | 100k | 6.68 |
| 2017-09-30 | $819k | 100k | 8.19 |
| 2017-06-30 | $449k | 100k | 4.49 |
| 2017-03-31 | $551k | 100k | 5.51 |
| 2016-12-31 | $405k | 100k | 4.05 |
| 2016-09-30 | $705k | 100k | 7.05 |
| 2016-06-30 | $815k | 100k | 8.15 |
| 2016-03-31 | $813k | 100k | 8.13 |
| 2015-12-31 | $1.2M | 100k | 12.06 |
| 2015-09-30 | $1.2M | 100k | 11.97 |
| 2015-06-30 | $1.8M | 100k | 18.33 |